Drug interactions
Glimepiride-pioglitazone + Topiramate
Severity: Minor
Glimepiride-pioglitazone and Topiramate: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Topiramate is a weak CYP3A4 inducer at higher doses and may slightly lower pioglitazone exposure. The clinical consequence is likely small, and any effect on glucose control would be modest.
What this interaction means in plain words
Glimepiride-pioglitazone and Topiramate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Glimepiride-pioglitazone belongs to Endocrine; Topiramate belongs to Central Nervous System.
Why it happens
Weak induction of CYP3A4 by topiramate may modestly increase pioglitazone metabolism.
What to do
No dose adjustment is usually required; review glycemic control if response to pioglitazone appears reduced.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Topiramate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Other interactions of Topiramate
Frequently asked questions
Can I take Glimepiride-pioglitazone with Topiramate?
MediHelp rates the interaction as minor. Glimepiride-pioglitazone and Topiramate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Topiramate is a weak CYP3A4 inducer at higher doses and may slightly lower pioglitazone exposure. The clinical consequence is likely small, and any effect on glucose control would be modest.
How serious is the interaction between Glimepiride-pioglitazone and Topiramate?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is usually required; review glycemic control if response to pioglitazone appears reduced.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
